Vitalhub (TSE:VHI) Hits New 52-Week High Following Analyst Upgrade

Vitalhub Corp. (TSE:VHI)’s stock price reached a new 52-week high during mid-day trading on Tuesday after Cormark raised their price target on the stock from C$7.50 to C$8.00. The stock traded as high as C$7.40 and last traded at C$7.35, with a volume of 17781 shares. The stock had previously closed at C$7.28.

Separately, Canaccord Genuity Group upped their price objective on Vitalhub from C$7.50 to C$8.00 and gave the stock a “buy” rating in a research report on Monday, May 13th.

Vitalhub Trading Up 1.1 %

The firm has a market capitalization of C$371.56 million, a PE ratio of 73.30, a P/E/G ratio of 2.61 and a beta of 1.23. The company has a fifty day moving average price of C$6.59 and a two-hundred day moving average price of C$5.55.

Vitalhub (TSE:VHI) last posted its quarterly earnings data on Thursday, May 9th. The company reported C$0.04 EPS for the quarter, missing the consensus estimate of C$0.07 by C($0.03). The company had revenue of C$15.26 million for the quarter, compared to analysts’ expectations of C$14.12 million. Vitalhub had a net margin of 8.66% and a return on equity of 5.78%. As a group, equities research analysts predict that Vitalhub Corp. will post 0.2700115 earnings per share for the current year.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.